188 related articles for article (PubMed ID: 38170544)
1. Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy.
Harris E
JAMA; 2024 Jan; 331(4):280. PubMed ID: 38170544
[No Abstract] [Full Text] [Related]
2. Discontinued CRISPR gene therapy for sickle-cell disease improves symptoms.
Carvalho T
Nat Med; 2023 Nov; 29(11):2669-2670. PubMed ID: 37783810
[No Abstract] [Full Text] [Related]
3. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
Wen J; Tao W; Hao S; Zu Y
J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Mehta J
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107196
[No Abstract] [Full Text] [Related]
5. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Meisel R
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107195
[No Abstract] [Full Text] [Related]
6. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply.
Frangoul H; Ho TW; Corbacioglu S
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107197
[No Abstract] [Full Text] [Related]
7. Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
Hollister BM; Gatter MC; Abdallah KE; Armsby AJ; Buscetta AJ; Byeon YJJ; Cooper KE; Desine S; Persaud A; Ormond KE; Bonham VL
CRISPR J; 2019 Dec; 2(6):441-449. PubMed ID: 31742431
[TBL] [Abstract][Full Text] [Related]
8. Treating Genetic Disorders Using State-Of-The-Art Technology.
Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Khan FA; Rehman K
Curr Issues Mol Biol; 2018; 26():33-46. PubMed ID: 28879854
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
Lin WV; Stout JT; Weng CY
Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
[No Abstract] [Full Text] [Related]
10. Tweaking genes with CRISPR or viruses fixes blood disorders.
Kaiser J
Science; 2020 Dec; 370(6522):1254-1255. PubMed ID: 33303593
[No Abstract] [Full Text] [Related]
11. CRISPR gene therapy shows promise against blood diseases.
Ledford H
Nature; 2020 Dec; 588(7838):383. PubMed ID: 33299166
[No Abstract] [Full Text] [Related]
12. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
13. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
14. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
15. Imagine CRISPR cures.
Urnov FD
Mol Ther; 2021 Nov; 29(11):3103-3106. PubMed ID: 34710352
[No Abstract] [Full Text] [Related]
16. Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.
Hossain MA; Bungert J
Mol Ther; 2017 Mar; 25(3):561-562. PubMed ID: 28190778
[No Abstract] [Full Text] [Related]
17. Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation.
Chu SH; Packer M; Rees H; Lam D; Yu Y; Marshall J; Cheng LI; Lam D; Olins J; Ran FA; Liquori A; Gantzer B; Decker J; Born D; Barrera L; Hartigan A; Gaudelli N; Ciaramella G; Slaymaker IM
CRISPR J; 2021 Apr; 4(2):169-177. PubMed ID: 33876959
[TBL] [Abstract][Full Text] [Related]
18. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
19. CRISPR in personalized medicine: Industry perspectives in gene editing.
Hong A
Semin Perinatol; 2018 Dec; 42(8):501-507. PubMed ID: 30376985
[TBL] [Abstract][Full Text] [Related]
20. The realization of CRISPR gene therapy.
Ma Y; Qi LS
Nat Chem Biol; 2024 Jul; 20(7):791-795. PubMed ID: 38872012
[No Abstract] [Full Text] [Related]
[Next] [New Search]